Attention-deficit/hyperactivity disorder in adults: an overview (Q33911442)

30 July 2017

1 reference

title

Attention-deficit/hyperactivity disorder in adults: an overview (English)

1 reference

attention deficit hyperactivity disorder

30 July 2017

0 references

1 reference

1

1 reference

30 July 2017

2

Biederman J

1 reference

30 July 2017

Spencer T

3

1 reference

30 July 2017

Wilens T

4

1 reference

30 July 2017

Seidman LJ

5

1 reference

30 July 2017

Mick E

6

1 reference

30 July 2017

Doyle AE

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

30 July 2017

Biological Psychiatry

1 reference

30 July 2017

48

1 reference

30 July 2017

1

1 reference

30 July 2017

9-20

1 reference

Attention deficit hyperactivity disorder in childhood among adults with major depression

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Hyperactivity and alcoholism: familial and behavioral correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A Four-Year Follow-up of Hyperactive Boys with and without Conduct Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Gender and comorbid psychopathology in adolescents with alcohol dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Gender differences in a sample of adults with attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Hyperactive boys and their brothers. A 25-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Attention dysfunction and psychopathology in college men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Toward a pathophysiology of attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Is attention deficit hyperactivity disorder familial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Symptom reports by adults with attention deficit hyperactivity disorder: are they influenced by attention deficit hyperactivity disorder in their children?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Neurobiology of attention-deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Are there cognitive subtypes in adult attention deficit/hyperactivity disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Gender differences in ADHD: a meta-analysis and critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Hyperactive boys almost grown up. I. Psychiatric status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Psychological and academic functioning in college students with attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Presentation of unrecognized attention deficit hyperactivity disorder in college students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Age-dependent decline of attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Externalizing behavior problems and academic underachievement in childhood and adolescence: causal relationships and underlying mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

The utility of neuropsychological tests in evaluation of Attention-Deficit/ Hyperactivity Disorder (ADHD) versus depression in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Neuropsychological testing in adult attention deficit hyperactivity disorder: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Methylphenidate effects on symptoms of attention deficit disorder in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Adult psychiatric disorders in parents of hyperactive children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Executive functions and developmental psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Neuropsychological function in adults with attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Tricyclic antidepressant treatment of children with ADHD and tic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Is attention-deficit hyperactivity disorder in adults a valid disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Psychosocial history, minimal brain dysfunction and differential drinking patterns of male alcoholics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

Relationship of neuropsychological performance to primary alcoholism and self-reported symptoms of childhood minimal brain dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900889-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)00889-1

1 reference

30 July 2017

1 reference